PeerCurrent.com|Stay current with the people and research shaping what comes next.

Your Feed AI Summary Saved Board Expert Discussion This Week in Your Field

Follows Journals Trials Guidelines Markets

Researcher

Takayuki Takahama

Kindai University

1 development in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

For You Latest Breakthroughs Trials Reviews Guidelines

Latest

Everything in the corpus, newest first.

AUG 7, 2026 · JOURNAL ARTICLE

Five‐Year Trends in Biomarker Testing and Targeted Therapy for NSCLC: A Patient‐Initiated Nationwide Survey in Japan

Cancer Science

A large retrospective cohort study documenting real-world trends in biomarker testing adoption and treatment patterns in advanced NSCLC, confirming expected shifts toward multigene testing while identifying a persistent care gap.

Important Confirmatory EvidenceCancer Genomics and Diagnostics Takayuki Takahama Lung Cancer Treatments and Mutations

Reported

Sample size24047

Study periodApril 2019 to May 2024

Number of hospitals300

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support